AebiS., Kurdi-HaidarB., GordonR., CenniB., ZhengH., FinkD., ChristenR.D., BolandC.R., KoiM., FishelR., HowellS.B.: Loss of DNA mis match repair in acquired resistance to cisplatin. Cancer Res., 56: 3087–3090, 1996.
2.
PapamichaelD., JoelS.P., SeymourM.T., RichardsF., Bower-bankM., SlevinM.L.: Pharmacokinetic (PK) interaction between 5-fluorouracil (5-FU) and oxaliplatin (L-OHP). Proc. Am. Soc. Clin. Oncol., abst. 777, 1998.
3.
AndréT., De GramontA., LouvetC., CarolaE., LotzJ.P., Maindrault-GoebelF., BeerblockK., IzraelV., KrulikM.: Bimonthly CPT-11 with leucovorin (LV) and 5-fluorouracil (5-FU) in pretreated metastatic colorectal cancer (FOLFIRI). Proc. Am. Soc. Clin. Oncol., abst. 1051, 1998.